Atrial fibrillation (AF) is the most common cardiac arrhythmia with a worldwide prevalence of approximately 2% (3, 4, 5). The occurrence of the disease depends on age, the prevalence among people under 60 years old is less than 1%, among people 80 years old and older it is 7...9%. Based on prevalence ind...
Macle, L;
Cairns, J;
Leblanc, K;
Tsang, T;
Skanes, A;
Cox, JL;
Healey, JS;
Bell, A;
Pilote, L;
Andrade, JG;
Mitchell, LB;
Atzema, C;
Gladstone, D;
Sharma, M;
Verma, S;
Connolly, S;
Dorian, P;
Parkash, R;
Talajic, M;
Nattel, S;
Verma, A.
The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF pa...
Anticoagulantes,
Cardiotónicos,
Inhibidores de Agregación Plaquetaria,
Digoxina,
Magnesio,
Síndrome Coronario Agudo/terapia,
Algoritmos,
Anticoagulantes/uso terapéutico,
Apéndice Atrial/cirugía,
Fibrilación Atrial,
Estimulación Cardíaca Artificial,
Cardiotónicos/efectos adversos,
Ablación por Catéter,
Cardiotónicos/administración & dosificación,
Fibrilación Atrial/terapia,
Fibrilación Atrial/complicaciones,
Hemorragia/inducido químicamente,
Hemorragia/prevención & control,
Magnesio/uso terapéutico,
Intervención Coronaria Percutánea,
Inhibidores de Agregación Plaquetaria/uso terapéutico,
Complicaciones Posoperatorias/prevención & control,
Infarto del Miocardio con Elevación del ST/terapia,
Accidente Cerebrovascular/prevención & control,
Enfermedad de la Arteria Coronaria/complicaciones,
Digoxina/administración & dosificación,
Digoxina/efectos adversos,
Quimioterapia Combinada,
Inhibidores del Factor Xa/uso terapéutico,
Fibrinolíticos/uso terapéutico,
Inhibidores del Factor Xa
This guideline covers the care and treatment of people with, or at risk of developing, chronic kidney disease. It aims to prevent or delay the progression of chronic kidney disease, reduce or prevent the development of complications, and reduce the risk of cardiovascular disease....
Mortensen, K;
Nilsson, M;
Slim, K;
Schäfer, M;
Mariette, C;
Braga, M;
Carli, F;
Demartines, N;
Griffin, SM;
Lassen, K.
"BACKGROUND:
Application of evidence-based perioperative care protocols reduces complication rates, accelerates recovery and shortens hospital stay. Presently, there are no comprehensive guidelines for perioperative care for gastrectomy.
METHODS:
An international working group within the Enhanced Recove...
Anticoagulantes,
Catárticos,
Consumo de Bebidas Alcohólicas,
Analgesia Epidural,
Profilaxis Antibiótica,
Consejo,
Descompresión Quirúrgica,
Suplementos Dietéticos,
Drenaje,
Gastrectomía,
Trastornos del Metabolismo de la Glucosa,
Hipotermia,
Bloqueo Nervioso,
Apoyo Nutricional,
Cuidados Posoperatorios,
Complicaciones Posoperatorias,
Náusea y Vómito Posoperatorios,
Cuidados Preoperatorios,
Prevención del Hábito de Fumar,
Desequilibrio Hidroelectrolítico,
Anticoagulantes/uso terapéutico,
Desequilibrio Hidroelectrolítico/prevención & control,
Reposo en Cama,
Catárticos/uso terapéutico
El objetivo fundamental de este documento es establecer recomendaciones, basadas en criterios de eficacia, seguridad y eficiencia, para la elección del tratamiento anticoagulante destinado a la prevención de las complicaciones tromboembolias asociadas a la fibrilación auricular no valvula....
Zawilska, Krystyna;
Jaeschke, Roman;
Tomkowski, Witold;
Mayzner-Zawadzka, Ewa;
Niżankowski, Rafat;
Olejek, Anita;
Pasierski, Tomasz;
Torbicki, Adam;
Undas, Anetta;
Arkadiusz, Jawień;
Gajewski, Piotr;
Sznajd, Jan;
Brożek, Jan.
The overall objective of the Polish guidelines for the prevention and treatment of venous thromboembolism is to increase patient benefit and safety by appropriate prevention and treatment of deep vein thrombosis and pulmonary embolism as well as proper management of the complications associated with anti...
